Most dialysis operators are not overpaying for the wrong product.

They are overpaying for the wrong supply structure.

The consumable itself is rarely where margin disappears. It disappears in the layers around it: the freight terms, the order timing, the emergency procurement, the overstock, the exchange rate exposure. By the time those costs are counted, the unit price agreed at the start of the year means very little.

The true cost of each treatment is built across your entire supply chain.

• Reactive procurement — ordering when you run low rather than against a planned cycle inflates both unit cost and freight cost

• Emergency orders — when supply cycles fail, emergency procurement costs 20–40% more than planned orders

• Freight volatility — shipping cost fluctuations on unplanned orders can double the landed cost of a shipment

• Exchange rate exposure — long payment cycles in USD create currency risk that compounds across every order

Unit price looks competitive. Total treatment cost tells a very different story.

THE REAL COST OF DIALYSIS ISN'T JUST THE PRODUCT

It's freight. It's timing. It's how supply is structured

WHERE THE COST ACTUALLY BUILDS

WHAT STRUCTURAL CHANGE ACHIEVES

When supply is planned against treatment demand rather than managed reactively, the economics shift.

In multiple markets across Africa and the Caribbean, operators who restructured their supply chain with SHK Medical reduced total treatment cost by up to 30%.

Not by switching to cheaper products.

Not by lowering clinical standards.

By correcting how supply is planned, sourced, and sequenced.

UP TO 30%

reduction in total treatment cost. Achieved across multiple African and Caribbean markets.

HOW WE BUILD THE STRUCTURE

What SHK Medical provides is not just a product range.

What SHK Medical provides is not just a product range.

It is a supply system — built around your actual treatment demand, your shipping environment, and your cost pressure.

The architecture is different by design. Most suppliers buy from a manufacturer, ship to their own warehouse, then sell and ship again to the end user. 2 x shipments. 2 x customs clearances. 2 x rounds of port handling and inland transport. Warehouse rental, staff, temperature control — every one of those costs absorbed into the price the operator eventually pays.

We removed that layer entirely. Direct shipment from manufacturer to end user. One shipping leg. One customs clearance. One landed cost. We pioneered this model in Africa 25 years ago when the industry considered it too risky. Today it is standard practice. The cost saving it created then is the same cost saving operators benefit from now.

• OEM-approved consumables compatible with Fresenius, Baxter, Nipro, B.Braun, Nikkiso, and other platforms

• Supply cycles planned against your patient volume — not a generic distribution schedule

• Container-scale and consolidated freight models that reduce per-unit landed cost

• Logistics structured for long shipping cycles, port environments, and freight volatility

• Citrasate® — a concentrate option that reduces heparin dependency and lowers medication cost per session

• Local concentrate production where it eliminates the largest single import cost permanently